Overview
Malignant peripheral nerve sheath tumors (MPNSTs) are
sarcomas which originate from peripheral nerves or from cells associated with
the nerve sheath, such as Schwann cells, perineural cells, or fibroblasts.
Symptoms include lump or swelling in the in the soft tissue, numbness, burning
or having that pins and needles feeling, weakness in the affected muscles and
dizziness or loss of balance. Treatment includes surgery, radiotherapy and
chemotherapy.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/1555343-peripheral-nerve-sheath-tumor-neurofibrosarcoma-pipeline-review-h1-2017
Report
Highlights
The Pharmaceutical and Healthcare latest pipeline guide
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline Review, H1 2017,
provides comprehensive information on the therapeutics under development for
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology), complete with
analysis by stage of development, drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type. The guide covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases.
The Peripheral Nerve Sheath Tumor (Neurofibrosarcoma)
(Oncology) pipeline guide also reviews of key players involved in therapeutic
development for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) and features
dormant and discontinued projects. The guide covers therapeutics under
Development by Companies /Universities /Institutes, the molecules developed by
Companies in Phase II and Phase I stages are 7 and 2 respectively. Similarly,
the Universities portfolio in Preclinical stages comprises 1 molecules,
respectively.
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology)
pipeline guide helps in identifying and tracking emerging players in the market
and their portfolios, enhances decision making capabilities and helps to create
effective counter strategies to gain competitive advantage. Additionally,
various dynamic tracking processes ensure that the most recent developments are
captured on a real time basis.
Major Scope of the report:
- The pipeline guide provides a snapshot of the global
therapeutic landscape of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma)
(Oncology).
- The pipeline guide reviews pipeline therapeutics for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide reviews pipeline therapeutics for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology) therapeutics and enlists all their major and minor projects.
Table of Contents
List of Figures
Introduction
Global Markets Direct Report Coverage
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Overview
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Companies Involved in Therapeutics Development
Bexion Pharmaceuticals LLC
EpiZyme Inc
Introduction
Global Markets Direct Report Coverage
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Overview
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Companies Involved in Therapeutics Development
Bexion Pharmaceuticals LLC
EpiZyme Inc
Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1555343-peripheral-nerve-sheath-tumor-neurofibrosarcoma-pipeline-review-h1-2017
About Us
Wise Guy
Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium
progressive statistical surveying, market research reports, analysis &
forecast data for industries and governments around the globe. Wise Guy Reports
understand how essential statistical surveying information is for your
organization or association. Therefore, we have associated with the top
publishers and research firms all specialized in specific domains, ensuring you
will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner
Relations & Marketing Manager
Ph:
+1-646-845-9349 (US)
Ph: +44 208
133 9349 (UK)
No comments:
Post a Comment